MY132777A - Inhalable formulation of a solution containing a tiotropium salt - Google Patents

Inhalable formulation of a solution containing a tiotropium salt

Info

Publication number: MY132777A
Authority: MY; Malaysia
Prior art keywords: solution containing; inhalable formulation; tiotropium salt; propellant; water
Prior art date: 2000-10-31

Application number

MYPI20014987A

Other languages

English (en)

Inventor

Karin Drechsel Dr

Barbara Niklaus-Humke Dr

Christel Schmelzer Dr

Barth Petra

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-31

Filing date

2001-10-29

Publication date

2007-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY132777(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-10-29 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2007-10-31 Publication of MY132777A publication Critical patent/MY132777A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

MYPI20014987A 2000-10-31 2001-10-29 Inhalable formulation of a solution containing a tiotropium salt MY132777A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10054042		2000-10-31

Publications (1)

Publication Number	Publication Date
MY132777A true MY132777A (en)	2007-10-31

Family

ID=7661727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI20014987A MY132777A (en)	2000-10-31	2001-10-29	Inhalable formulation of a solution containing a tiotropium salt

Country Status (33)

Country	Link
EP (1)	EP1335729A2 (es)
JP (1)	JP4559703B2 (es)
KR (1)	KR100983208B1 (es)
CN (1)	CN1237970C (es)
AR (1)	AR038765A1 (es)
AU (2)	AU2174102A (es)
BG (1)	BG66425B1 (es)
BR (1)	BR0115016A (es)
CA (1)	CA2427583C (es)
CZ (1)	CZ305033B6 (es)
DE (1)	DE10152369A1 (es)
EA (1)	EA009068B1 (es)
EC (1)	ECSP034570A (es)
EE (1)	EE05343B1 (es)
HK (1)	HK1060569A1 (es)
HR (1)	HRP20030337A2 (es)
HU (1)	HUP0301377A3 (es)
IL (2)	IL155676A0 (es)
ME (1)	ME00242B (es)
MX (1)	MXPA03003750A (es)
MY (1)	MY132777A (es)
NO (1)	NO332524B1 (es)
NZ (1)	NZ526024A (es)
PE (1)	PE20020518A1 (es)
PL (1)	PL361001A1 (es)
SA (1)	SA01220503B1 (es)
SK (1)	SK288031B6 (es)
TW (1)	TWI296934B (es)
UA (1)	UA76435C2 (es)
UY (1)	UY26991A1 (es)
WO (1)	WO2002036591A2 (es)
YU (1)	YU33103A (es)
ZA (1)	ZA200303045B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA02010565A (es)	2000-04-28	2004-05-17	Kosan Biosciences Inc	Produccion de policetidos.
US20030235538A1 (en)	2002-04-09	2003-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Method for the administration of an anticholinergic by inhalation
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
WO2005034871A2 (en) *	2003-10-09	2005-04-21	Inverseon, Inc.	Methods for treating diseases and conditions with inverse agonists
SE0303269L (sv) *	2003-12-03	2005-06-04	Microdrug Ag	Medicinsk produkt
JP4991693B2 (ja) *	2005-03-16	2012-08-01	メダファーマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	呼吸器疾患の治療のための抗コリン作用薬及びロイコトリエン受容体アンタゴニストの組み合わせ剤
WO2007140285A2 (en) *	2006-05-26	2007-12-06	Dey, L.P.	Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
CN100446770C (zh) *	2007-01-10	2008-12-31	上海现代药物制剂工程研究中心有限公司	丙酸培氯米松水雾剂
TR200907237A2 (tr) *	2009-09-23	2011-04-21	Bi̇lgi̇ç Mahmut	Tiotropyum kuru toz kombinasyonu
CN116196298A (zh) *	2018-07-26	2023-06-02	四川海思科制药有限公司	一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用
CN111936124A (zh) *	2018-07-26	2020-11-13	四川海思科制药有限公司	一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0504112A3 (en) *	1991-03-14	1993-04-21	Ciba-Geigy Ag	Pharmaceutical aerosol formulations
DE4203306A1 (de) *	1992-02-06	1993-08-12	Ig Spruehtechnik Gmbh	Asthma oder pulmonal-aerosolzubereitungen mit lecithin
UA62917C2 (en) *	1995-06-27	2004-01-15	Berinher Inhelheim Kg	Medicinal composition for generating propellant-free aerosols
US5824669A (en) *	1996-03-22	1998-10-20	Nitromed, Inc.	Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
EP0954318A1 (en) *	1996-06-04	1999-11-10	The Procter & Gamble Company	A nasal spray containing an intranasal steroid and an antihistamine
DE19653969A1 (de) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JPH10298107A (ja) *	1997-04-25	1998-11-10	Taisho Pharmaceut Co Ltd	医薬組成物
US6475467B1 (en) *	1998-08-04	2002-11-05	Jago Research Ag	Medicinal aerosol formulations
DE19847968A1 (de) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

2001
- 2001-10-24 BR BR0115016-2A patent/BR0115016A/pt active Pending
- 2001-10-24 CA CA002427583A patent/CA2427583C/en not_active Expired - Fee Related
- 2001-10-24 WO PCT/EP2001/012296 patent/WO2002036591A2/de active IP Right Grant
- 2001-10-24 MX MXPA03003750A patent/MXPA03003750A/es active IP Right Grant
- 2001-10-24 DE DE10152369A patent/DE10152369A1/de not_active Withdrawn
- 2001-10-24 AU AU2174102A patent/AU2174102A/xx active Pending
- 2001-10-24 ME MEP-2008-407A patent/ME00242B/me unknown
- 2001-10-24 YU YU33103A patent/YU33103A/sh unknown
- 2001-10-24 IL IL15567601A patent/IL155676A0/xx unknown
- 2001-10-24 HU HU0301377A patent/HUP0301377A3/hu unknown
- 2001-10-24 AU AU2002221741A patent/AU2002221741B2/en not_active Expired
- 2001-10-24 EP EP01992710A patent/EP1335729A2/de not_active Ceased
- 2001-10-24 NZ NZ526024A patent/NZ526024A/en not_active IP Right Cessation
- 2001-10-24 JP JP2002539350A patent/JP4559703B2/ja not_active Expired - Lifetime
- 2001-10-24 EE EEP200300202A patent/EE05343B1/xx unknown
- 2001-10-24 KR KR1020037006001A patent/KR100983208B1/ko active IP Right Grant
- 2001-10-24 EA EA200300483A patent/EA009068B1/ru not_active IP Right Cessation
- 2001-10-24 CZ CZ2003-1487A patent/CZ305033B6/cs not_active IP Right Cessation
- 2001-10-24 SK SK526-2003A patent/SK288031B6/sk not_active IP Right Cessation
- 2001-10-24 UA UA2003054960A patent/UA76435C2/uk unknown
- 2001-10-24 CN CNB018183271A patent/CN1237970C/zh not_active Expired - Lifetime
- 2001-10-24 PL PL01361001A patent/PL361001A1/xx not_active Application Discontinuation
- 2001-10-29 UY UY26991A patent/UY26991A1/es not_active Application Discontinuation
- 2001-10-29 PE PE2001001072A patent/PE20020518A1/es active IP Right Grant
- 2001-10-29 MY MYPI20014987A patent/MY132777A/en unknown
- 2001-10-29 TW TW090126752A patent/TWI296934B/zh not_active IP Right Cessation
- 2001-10-31 AR ARP010105088A patent/AR038765A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 2001-11-03 SA SA01220503A patent/SA01220503B1/ar unknown
2003
- 2003-04-16 BG BG107726A patent/BG66425B1/bg active Active
- 2003-04-17 ZA ZA200303045A patent/ZA200303045B/xx unknown
- 2003-04-28 HR HR20030337A patent/HRP20030337A2/hr not_active Application Discontinuation
- 2003-04-28 EC EC2003004570A patent/ECSP034570A/es unknown
- 2003-04-29 NO NO20031914A patent/NO332524B1/no not_active IP Right Cessation
- 2003-04-30 IL IL155676A patent/IL155676A/en active IP Right Grant
2004
- 2004-05-20 HK HK04103587A patent/HK1060569A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR100983208B1 (ko)	2010-09-20
IL155676A0 (en)	2003-11-23
SA01220503B1 (ar)	2007-03-10
PL361001A1 (en)	2004-09-20
TWI296934B (en)	2008-05-21
EA200300483A1 (ru)	2003-12-25
JP4559703B2 (ja)	2010-10-13
BG107726A (bg)	2004-11-30
EP1335729A2 (de)	2003-08-20
EE200300202A (et)	2003-10-15
CA2427583A1 (en)	2002-05-10
HUP0301377A2 (hu)	2003-10-28
HK1060569A1 (en)	2004-08-13
NO20031914D0 (no)	2003-04-29
ZA200303045B (en)	2004-04-22
EA009068B1 (ru)	2007-10-26
HUP0301377A3 (en)	2005-12-28
ME00242B (me)	2011-05-10
NZ526024A (en)	2005-10-28
KR20040010552A (ko)	2004-01-31
DE10152369A1 (de)	2002-05-08
CZ305033B6 (cs)	2015-04-08
UY26991A1 (es)	2002-06-20
AU2002221741B2 (en)	2007-04-05
AR038765A1 (es)	2005-01-26
CN1237970C (zh)	2006-01-25
UA76435C2 (en)	2006-08-15
ECSP034570A (es)	2003-06-25
MEP40708A (en)	2011-02-10
SK5262003A3 (en)	2003-10-07
WO2002036591A2 (de)	2002-05-10
SK288031B6 (sk)	2012-12-03
CN1473044A (zh)	2004-02-04
BR0115016A (pt)	2005-05-03
EE05343B1 (et)	2010-10-15
JP2004523482A (ja)	2004-08-05
CA2427583C (en)	2008-02-12
PE20020518A1 (es)	2002-07-12
BG66425B1 (bg)	2014-04-30
YU33103A (sh)	2006-05-25
NO332524B1 (no)	2012-10-08
IL155676A (en)	2012-05-31
CZ20031487A3 (cs)	2003-09-17
HRP20030337A2 (en)	2005-04-30
NO20031914L (no)	2003-06-23
WO2002036591A3 (de)	2002-07-25
MXPA03003750A (es)	2004-10-15
AU2174102A (en)	2002-05-15

Publication	Publication Date	Title
AP1572A (en)	2006-02-13	Crystalline monohydrate, method for producing the same and use thereof in the production of a medicament.
HUP0400333A2 (hu)	2004-12-28	Kristályos antikolinergikum, eljárás előállítására és alkalmazása gyógyszerkészítmény előállítására
MY132777A (en)	2007-10-31	Inhalable formulation of a solution containing a tiotropium salt
MXPA01012882A (es)	2003-06-24	Composiciones y metodos que comprenden gluconato de morfina.
PT2040703E (pt)	2010-01-19	Derivados de 2-benzoil-imidazopiridinas, sua preparação e sua aplicação em terapia
MY138940A (en)	2009-08-28	Inhalable formulation of a solution containing a tiotropium salt.
SE0102440D0 (sv)	2001-07-05	New compound
MY137249A (en)	2009-01-30	Aerosol formulation for inhalation containing a tiotropium salt
ATE258046T1 (de)	2004-02-15	Pharmazeutische, metamizol enthaltende brauseformulierung
ATE77238T1 (de)	1992-07-15	Primycin-loesungen.
MY105595A (en)	1994-11-30	Stable aqueous solutions of primycin pharmaceutical and cosmetic compositions containing these solutions and process for preparing same